Biotech · Private company · Coralville, IA, US
Viewpoint Molecular Targeting, Inc.
Track this companyFree. Adds Viewpoint Molecular Targeting, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Antibody-based prertargeted alpha particle therapy for ovarian cancerFiscal year 2026 · $1MNIH RePORTER 4R42CA287696-02 · fetched Nov 12, 2026
- Antibody-based prertargeted alpha particle therapy for ovarian cancerFiscal year 2024 · $391.6KNIH RePORTER 1R42CA287696-01 · fetched Nov 12, 2026